Analgesics - UK - September 2006

Table of Contents

• Issues in the Market
• Definitions
• Abbreviations
• Market in Brief
• Hit it hard and fast
• Value sales are suffering
• Convenience is king
• State interference
• Active ingredients
• Consolidation is key
• Positive future growth predicted
• Internal Market Environment
• Physiological factors
  • Figure 1: Selected complaints suffered from in the last 12 months, 2001-05
• Headaches
• Migraine
• Arthritis
• Bad back
• Other ailments
• Cultural attitudes to healthcare
  • Figure 2: Agreement with attitude statements on health, 2001-05
• Health is a priority for consumers
• Dr Dolittle
• Analgesics for sports injuries
  • Figure 3: Play or take part in selected sports regularly or occasionally, 2001-05
• Broader Market Environment
• Changing nature of healthcare provision
• Taking responsibility -- self-care
• How the Internet fits into healthcare provision
  • Figure 4: Reasons for visiting healthcare websites in the last 3 months, 2002-06
• Consumers use the Internet for fact-finding
• Low Internet analgesics sales
• Changing demographics
• Ageing population
  • Figure 5: UK population, 2001 and 2006
• More busy ABs
  • Figure 6: UK population by socio-economic status, 2001 and 2006
• Competitive Context
• Analgesics on prescription
• Pharmacy and general sales of analgesics
• Avoiding the restrictions
• Promotional restrictions
• Clampdown on 'BOGOF' (buy one get one free) promotions
• Strengths and Weaknesses
• New Product Briefs
• Market Sizes and Forecast
• Growth coming from pharmacy sector
  • Figure 7: Sales of analgesics, 2001-11
• Downward price pressure from grocery multiples
• Volume and pack sizes
  • Figure 8: Volume and unit sales**, 2003-05
• The Future
• Growing older painlessly?
  • Figure 9: projected UK population by age, 2006-11
• Targeted solutions
• The future is upwardly mobile
  • Figure 10: Projected UK population, by socio-economic status, 2006-11
• Segment Performance
• Active ingredients
  • Figure 11: Retail sales of analgesics, by active ingredient, 2004-06
• Ibuprofen
• Paracetamol
• Aspirin
• Paediatric formulations
• Paracetamol and codeine
• Paracetamol and aspirin
• Ibuprofen and Codeine
• Others
• New migraine treatments/ingredients join the OTC market
• Triptans
• Menthol
• Format type
• Tablets and caplets dominate
  • Figure 12: Sales of analgesics, by product format, 2004-06
• Capsules catch on
• Market Share
• Own-label has been the big success story
• Brand shares
  • Figure 13: Brand shares of analgesics, 2004 and 2006
• Companies and Products
• GlaxoSmithKline
• Wyeth Consumer Healthcare
• Pfizer
• Reckitt Benckiser
• Bayer (including Roche Consumer Health)
• SSL International
• Boots the Chemist
• Brand Communication and Promotion
  • Figure 14: Main monitored media spend for analgesics, 2001-05
• Maintaining brand awareness
• Analgesic marketing peaks in 2004
• Media usage
  • Figure 15: Main monitored media research, 2005
• Above the line
• Seasonality
  • Figure 16: Main monitored media spend, 2005
• Winter woes
• Channels to Market
• Evolving distribution map
  • Figure 17: Retail sales of analgesics, by type of outlet, 2004-06
• Groceries fight to hold their own
• P products give pharmacies a big market niche
• Niche outlets
• The Consumer -- Usage and Frequency
• Ailments suffered
• Young headaches
• Migraines -- education is key
• Old aches and pains -- rheumatism and arthritis
• Usage and penetration
• Headache remedies and analgesics
  • Figure 18: Usage of headache remedies and analgesics in the last 12 months, 2001-05
• Targeted formulations lead to decline in frequency of use?
• Retired consumers have contrasting usage habits
  • Figure 19: Usage of analgesics and headache remedies, by age, 2005
• Sporting injuries
• Younger AB consumers need fast acting pain relief
• Women are the heaviest users
  • Figure 20: Usage of analgesics and headache remedies, by gender and lifestage, 2005
• Family most likely to be medium users
• Usage by attitudes to health and wellbeing
  • Figure 21: Usage of headache remedies and analgesics in the last 12 months, by agreement with attitude statements on health, 2005
• Repertoire of illnesses
• Fewer more effective treatments
• Prevention better than cure
• Usage by incidence of ailments
  • Figure 22: Usage of headache remedies and analgesics in the last 12 months, by complaints suffered from in the last 12 months, 2005
• Symptoms drive use of analgesics
• Recurring and persistent conditions
• Usage by sporting activities
  • Figure 23: Usage of headache remedies and analgesics in the last 12 months, by play or take part in selected sports regularly, 2005
• Symptom or cure
• The Consumer -- Who, Why, What?
• Format used
  • Figure 24: Products format used, May 2006
• Traditional tablets
• Family-friendly formats
• Topical analgesics
  • Figure 25: Usage of topical painkillers ie creams, gels, rubs, sprays, May 2006
• Refresh and revitalise
• Appendix
• Brand Communication and Promotion
  • Figure 32: Main monitored media spend for analgesics, by advertiser (company and brand), 2003-05
• The Consumer -- Usage and Frequency
• Incidence of ailments
  • Figure 33: Selected complaints suffered from in the last 12 months, by demographic sub-group, 2005
• Usage of analgesics
  • Figure 34: Usage of headache remedies and analgesics in the last 12 months, by demographic sub-group, 2005
• The Consumer -- Who, Why, What?
• Format usage
  • Figure 35: Products format used, by detailed demographics, May 2006
• The Consumer -- Attitudes and Behaviours
  • Figure 36: Attitudes to analgesics, January 2006
  • Figure 37: Attitudes to analgesics, by selected demographics, May 2006